Clinical Guidelines

Melanomas: Clinical Decision Making with AI

Artificial intelligence support for opticians assessing small pigmented choroidal lesions

Share

  • 1

    Increasing incidents of small pigmented lesions in eye screenings.

  • 2

    Challenge of distinguishing between benign nevi and melanomas.

  • 3

    MelAInoma algorithm shows promise in aiding diagnosis.

  • 4

    Participants report increased confidence and accuracy with the tool.

  • 5

    Study suggests significant reduction in false positives.

  • 6

    Phased rollout of MelAInoma planned for usability assessment.

  • 7

    Growing need for effective decision-making with limited ocular oncologists.

Original Source(s)

Melanomas: Clinical Decision Making with AI

Artificial intelligence support for opticians assessing small pigmented choroidal lesions

  • by Alun Evans

  • July 8, 2025

  • 3 min

Related Content

Patterns of Spread in Ocular Melanoma

Study examines lymphatic and distant metastasis risk

Light-activated Suprachoroidal Therapy for the First-line Treatment of Indeterminate Lesions and Small Choroidal Melanoma

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

GUEST EDITORIAL An Inflection Point for Retinal Therapy

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.